Editor's note: With permission from Skyhorse Publishing, we are pleased to offer you a free download of chapter 19, A License to Kill? by Mark Blaxill and Dan Olmsted. The article is included the just-relased paperback version of "Vaccine Epidemic," edited by Louise Kuo Habakus and Mary Holland.
According to the publishers: "Gardasil is the newest childhood vaccine to be licensed by the FDA and recommended for universal use by the CDC. Judge for yourself whether this 'public-private partnership' prioritizes the best interests of our children. Or is it a perfect example of corporate greed, biased science, and coercive government? Please let us know what you think." (That's Jessica Ericzon who died following Gardasil vaccination in the photo. And her head stone.)
This article identifies a pattern of conflicts of interest at the Department of Health and Human Services – and ultimately throughout the federal government -- involving Merck’s controversial Gardasil vaccine against HPV, or human papilloma virus.
- Researchers at the National Cancer Institute invented critical technology for the vaccine.
- Another National Institutes of Health office filed for patents on the technology, licensed those patent rights to vaccine manufacturers and eventually received royalties from Merck, Gardasil’s manufacturer.
- The Food and Drug Administration supervised the clinical trials and granted Merck a license application for the first HPV vaccine.
- Just three weeks later, an advisory committee at the Centers for Disease Control recommended universal HPV vaccination for women from nine to twenty-six years of age, guaranteeing Gardasil would reach blockbuster status for Merck: annual revenues of well over $1 billion.
- Subsequently, agencies within FDA and CDC have been responsible for monitoring Gardasil’s safety in the field,
- As officials within the Health Resources Services Administration brace themselves to sit in judgment over a new wave of vaccine injury claims.
Meanwhile, key officials involved in the decisions rotate through a revolving door into private industry. These conflicts are both extraordinary in scope and poorly understood by the general public. But they are central to understanding why unsafe and unnecessary vaccines are approved and recommended – why we have a vaccine epidemic.